Analysts significantly raised near-term forecasts for Palantir Technologies. The consensus 2026 revenue estimate increased from $6.3 billion to $7.3 billion. Statutory earnings per share (EPS) forecasts rose 67% to $1.14. Zacks Investment Research issued a #2 (Buy) rating for the company. This rating anticipates 78.7% year-over-year earnings growth.
Palantir established a strategic partnership with Cognizant. This collaboration focuses on AI-driven modernization for healthcare and enterprise clients. The initiative utilizes Palantir’s existing software platforms.
The stock recently declined despite positive revisions and strong quarterly results. Market reports attribute this movement to broader profit-taking within the AI sector. This follows a period of substantial gains for the industry.